BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10997438)

  • 1. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI.
    Kvistad KA; Rydland J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Eur Radiol; 2000; 10(9):1464-71. PubMed ID: 10997438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
    Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
    Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
    Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
    AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro diagnosis of axillary lymph node metastases in breast cancer by spectrum analysis of radio frequency echo signals.
    Tateishi T; Machi J; Feleppa EJ; Oishi R; Jucha J; Yanagihara E; McCarthy LJ; Noritomi T; Shirouzu K
    Ultrasound Med Biol; 1998 Oct; 24(8):1151-9. PubMed ID: 9833584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
    Kuerer HM; Newman LA; Fornage BD; Dhingra K; Hunt KK; Buzdar AU; Ames FC; Ross MI; Feig BW; Hortobagyi GN; Singletary SE
    Ann Surg Oncol; 1998 Dec; 5(8):673-80. PubMed ID: 9869512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
    Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
    Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging for axillary staging in patients with breast cancer.
    Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
    J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
    Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
    Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
    Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
    Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
    Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
    J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging and invasive breast cancer: primary lesion kinetics correlated with axillary lymph node extracapsular extension.
    Loiselle CR; Eby PR; Peacock S; Kim JN; Lehman CD
    J Magn Reson Imaging; 2011 Jan; 33(1):96-101. PubMed ID: 21182126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.